FINWIRES · TerminalLIVE
FINWIRES

Market Chatter: Possible US, Iran Near Deal Ties $20 Billion Asset Release to Uranium Surrender

-- The US and Iran are negotiating a three-page framework to end the conflict, including a proposal to release up to $20 billion in frozen Iranian funds in exchange for Tehran relinquishing its stockpile of enriched uranium, Axios reported on Friday, citing multiple US officials and sources briefed on the talks.

The talks have reportedly made steady progress in recent days, though significant differences remain. A potential agreement along these lines could bring an end to hostilities, but risks backlash from Iran critics in Washington and among US allies, Axios reported.

Donald Trump said Thursday that American and Iranian negotiators are expected to meet for a second round of talks this weekend.

At the center of the negotiations is Iran's stockpile of nearly 2,000 kilograms of enriched uranium, including roughly 450 kg enriched to 60% purity. US officials say a key objective is ensuring Iran cannot access or use that material.

Iran, meanwhile, is said to be seeking financial relief. The sides are negotiating both the fate of the uranium stockpile and the scale and conditions of sanctions relief, including how unfrozen funds could be used.

Earlier in the talks, the US had proposed releasing $6 billion for humanitarian purchases, while Iran sought $27 billion. The current figure under discussion is about $20 billion, though one US official described the proposal as just one option among several.

Disagreements persist over the handling of Iran's nuclear material. Washington has pushed for the removal of all enriched uranium from Iran, while Tehran has proposed "down-blending" it domestically. A compromise under consideration would involve shipping some highly enriched uranium to a third country while converting the remainder inside Iran under international supervision.

Axios reported that the draft memorandum of understanding also includes a proposed "voluntary" moratorium on uranium enrichment. The US has called for a 20-year halt, while Iran has countered with a five-year pause.

Under the draft terms, Iran would be permitted to operate nuclear research reactors for medical isotope production, but would commit to keeping all nuclear facilities above ground. Existing underground sites would remain inactive.

Subsequent to the publication of the Axios report, Trump posted on Truth Social, "The USA will get all nuclear 'dust,' created by our great B2 Bombers - No money will exchange hands in any way, shape, or form."

He added that the deal is in no way subject to Lebanon, but said that the US will "separately work with Lebanon," and deal with the Hezbollah situation "in an appropriate manner."

"Israel will not be bombing Lebanon any longer," he said, adding that the US had "prohibited" them from doing so.

White House spokesperson Anna Kelly told, "Only announcements from President Trump or the White House - not anonymous sources - should be taken as fact. Productive conversations with Iran continue, but we will not negotiate via the press."

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

相关文章

Asia

Euroz Hartleys表示,Emerald Resources的勘探成功支撑了其多元资产增长。

周二,Euroz Hartleys在一份报告中指出,Emerald Resources(ASX:EMR)近期在西澳大利亚的Dingo Range金矿项目及其他地区的勘探成功,巩固了该公司多元化资产增长和产能扩张的战略。 Euroz Hartleys表示,Dingo Range的钻探证实了强烈的矿化作用,露天矿资源的加密钻探结果也印证了这一点。此外,Freeman's Find矿床持续延伸,并取得了显著的矿化截获。 与此同时,柬埔寨Memot金矿项目的密集反循环加密钻探预计将有助于储量转化,同时评估潜在的矿石损失和稀释情况,该项目的资源量仍有增长空间。 这家股票研究公司表示,Okvau金矿的钻探持续显示出地下增产潜力,这支持延长矿山寿命,并有望在目前每年约10万至12万盎司的产量基础上实现未来的增产。鉴于该公司目前已产生大量现金流,这一点至关重要。 Euroz Hartleys维持对该股的买入评级,目标价为8.10澳元。 Emerald Resources的股价在周三的交易中下跌了2%。

$ASX:EMR
Asia

阿旃陀制药印度派坦工厂检查后,收到美国FDA五项观察意见。

据提交给印度证券交易所的文件显示,阿旃陀制药(Ajanta Pharma,NSE:AJANTPHARM,BOM:532331)位于印度马哈拉施特拉邦派坦的生产工厂已完成美国食品药品监督管理局(FDA)的检查,并收到FDA提出的五项观察意见。 FDA于4月13日至21日对该工厂进行了检查,并最终出具了包含五项观察意见的483表格。 该公司表示将在规定的时间内对FDA作出回应。 该公司股价在最近的交易中下跌了近1%。

$BOM:532331$NSE:AJANTPHARM
Asia

Pateo Connect与Horizon Robotics Technology合作开发人工智能驱动车辆系统

据周三在香港交易所发布的公告显示,上海帕特奥互联科技股份有限公司(港交所代码:2889)与北京地平线机器人技术研发有限公司签署合作协议。 双方将携手开发智能座舱和自动驾驶的集成解决方案,并推进机器人和车辆智能领域的应用。 两家公司还计划通过共享客户资源和开拓海外汽车市场,共同拓展全球业务。

$HKG:2889